Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.

NCT03156504 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03156504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03156504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2017
Completion date
March 12, 2020
Enrollment
75 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder, bipolar ii disorder, major depression, unipolar depression